Pure Financial Advisors LLC Acquires Shares of 3,344 Stryker Corporation $SYK

Pure Financial Advisors LLC bought a new position in shares of Stryker Corporation (NYSE:SYK - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 3,344 shares of the medical technology company's stock, valued at approximately $1,053,000.

Several other large investors have also made changes to their positions in SYK. State Street Corp raised its holdings in Stryker by 2.1% during the 4th quarter. State Street Corp now owns 15,254,407 shares of the medical technology company's stock worth $5,374,731,000 after purchasing an additional 311,507 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Stryker by 0.9% during the 4th quarter. Geode Capital Management LLC now owns 7,535,572 shares of the medical technology company's stock worth $2,636,238,000 after buying an additional 69,851 shares during the period. Wellington Management Group LLP raised its stake in shares of Stryker by 22.6% during the fourth quarter. Wellington Management Group LLP now owns 6,493,276 shares of the medical technology company's stock worth $2,282,192,000 after buying an additional 1,198,665 shares during the last quarter. Norges Bank acquired a new position in Stryker in the fourth quarter valued at approximately $1,822,272,000. Finally, Bank of America Corp DE bought a new position in Stryker in the second quarter valued at approximately $1,404,284,000. Institutional investors and hedge funds own 77.09% of the company's stock.

Stryker Stock Down 0.2%

Shares of Stryker stock opened at $330.08 on Thursday. The company has a market capitalization of $126.61 billion, a P/E ratio of 34.21, a price-to-earnings-growth ratio of 2.11 and a beta of 0.76. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. The business has a 50-day moving average of $328.37 and a two-hundred day moving average of $331.72. Stryker Corporation has a 1 year low of $281.00 and a 1 year high of $396.86.

Stryker (NYSE:SYK - Get Free Report) last posted its earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The business had revenue of $6.59 billion during the quarter, compared to analysts' expectations of $6.58 billion. During the same period in the prior year, the business earned $3.13 EPS. Stryker's revenue for the quarter was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, equities analysts predict that Stryker Corporation will post 15.02 EPS for the current year.

Stryker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date is Wednesday, September 30th. Stryker's dividend payout ratio is 36.48%.

Analysts Set New Price Targets

Several analysts have commented on SYK shares. Canaccord Genuity Group dropped their target price on shares of Stryker from $435.00 to $400.00 and set a "buy" rating for the company in a research report on Friday, May 1st. Argus set a $370.00 price objective on Stryker in a research note on Thursday, July 9th. Leerink Partners cut their target price on Stryker from $410.00 to $407.00 and set an "outperform" rating on the stock in a research note on Friday, June 5th. Wolfe Research cut Stryker from an "outperform" rating to a "peer perform" rating in a report on Thursday, August 13th. Finally, BMO Capital Markets initiated coverage on Stryker in a research note on Wednesday, July 8th. They issued an "outperform" rating and a $369.00 price target for the company. One investment analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $386.28.

Insider Buying and Selling at Stryker

In other news, insider Debra King sold 826 shares of the business's stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total value of $277,783.80. Following the sale, the insider directly owned 6,210 shares in the company, valued at $2,088,423. The trade was a 11.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Dylan Bram Crotty sold 441 shares of the firm's stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $328.61, for a total transaction of $144,917.01. Following the transaction, the insider directly owned 6,102 shares of the company's stock, valued at $2,005,178.22. This represents a 6.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 351,267 shares of company stock valued at $118,197,701 in the last 90 days. 4.60% of the stock is currently owned by company insiders.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source